抗原定义性膜性肾病中的问题与注意事项
本综述探讨膜性肾病抗原检测结果评估中出现的疑问与注意事项,讨论组织抗原与临床场景不一致、一种抗原对应多种临床状况、多种抗原罕见共存以及狼疮膜性肾炎相关抗原对诊断或治疗的影响。
要点
- 膜性抗原与基础疾病关联强度不一,解读结果需谨慎。
- 一种抗原可对应多种临床状况,一种状况也可对应多种抗原。
- 组织或血液中多种膜性相关抗原共存罕见。
核心结论
- 随着膜性肾病自身抗原发现进展,日常实践中检测膜性抗原时需考虑抗原与基础疾病关联强度的差异。
研究设计与样本
- 综述,探讨膜性抗原检测结果评估中的问题与注意事项。
主要发现
- 组织抗原与临床场景不一致,重点关注磷脂酶A2受体。
- 一种抗原不等于一种临床状况,如结节病中可见膜性抗原异质性,神经表皮生长因子样1相关状况亦呈异质性。
- 组织或血液中多种膜性相关抗原共存罕见,如抗原钙黏蛋白7。
- 狼疮膜性肾炎相关抗原及其对诊断或治疗的影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Remarkable progress has been made in the discovery of autoantigens in membranous nephropathy. With increasing testing for membranous antigens in daily practice, it is important to consider the varying strength of associations between certain antigens and underlying conditions. This review explores questions and caveats that arise when assessing results of membranous antigen testing. Specifically, we will discuss: ( 1 ) discrepancy between tissue antigen and clinical scenario, focusing on phospholipase A2 receptor; ( 2 ) one antigen≠one clinical condition, i.e ., the heterogeneity of membranous antigens seen in one clinical condition (such as in sarcoidosis), and conversely, heterogeneity of conditions associated with one antigen (such as for neural epidermal growth factor-like 1); ( 3 ) rare presence of multiple membranous-associated antigens in tissue or blood (such as with antiprotocadherin 7); and ( 4 ) lupus membranous nephritis-related antigens and their influence on diagnosis or treatment.
引用
- Andeen NK, Kung VL, Avasare RS, et al. Questions and Caveats in Antigen-Defined Membranous Nephropathy. J Am Soc Nephrol. 2025. PMID: 40424085. doi:10.1681/ASN.0000000769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。